The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib

American Journal of Therapeutics
W C MaddreyG S Geis

Abstract

Celecoxib is a cyclooxygenase- (COX)-1-sparing inhibitor of COX-2 that is indicated for the treatment of osteoarthritis and rheumatoid arthritis. Many agents used for treating these diseases, both symptom-modifying and disease-modifying, are associated with the potential for hepatotoxicity. This article presents an analysis of the hepatic effects of celecoxib in 14 controlled studies of patients with arthritis (2 to 24 weeks' duration), in a long-term, open-label safety study (as long as 2 years), in 11 studies of patients receiving treatment for pain after oral or orthopedic surgery (up to 5 days' duration), and in five pharmacology studies. The overall incidence of hepatic adverse events in arthritis patients receiving celecoxib was similar to that for placebo but significantly lower than in the combined group of patients receiving nonsteroidal anti-inflammatory drugs (NSAIDs). The most commonly reported hepatic adverse events were elevations in liver transaminase levels, most of which occurred in patients receiving diclofenac. Similarly, clinically significant elevations of transaminase levels occurred more frequently with NSAIDs than with celecoxib. A pharmacology study performed in patients with mild or moderate hepatic im...Continue Reading

Citations

Nov 23, 2006·European Journal of Clinical Pharmacology·Domenico MotolaNicola Montanaro
May 10, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alaa RostomLoren Laine
Oct 21, 2003·QJM : Monthly Journal of the Association of Physicians·N O'ConnorA L Jones
Jul 7, 2001·BMJ : British Medical Journal·J P O'Beirne, S R Cairns
Aug 26, 2014·Expert Opinion on Pharmacotherapy·Carlo PalazziIgnazio Olivieri
Oct 9, 2013·Clinics in Liver Disease·Alberto Unzueta, Hugo E Vargas
Feb 22, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joan ClàriaVicente Arroyo
Dec 24, 2015·Gut and Liver·Tanvir HaquePaul H Hayashi
Jun 29, 2010·Pharmacoepidemiology and Drug Safety·Chang-Hsing LeePau-Chung Chen
Jul 26, 2003·Clinics in Liver Disease·Narci C Teoh, Geoffrey C Farrell
Oct 21, 2016·Expert Opinion on Drug Safety·Fernando BessoneRaúl J Andrade
Nov 28, 2002·The Annals of Pharmacotherapy·Antonio GriecoGiovanni Gasbarrini
Feb 2, 2018·Biochemistry Research International·Xiang ZhengHong-Yu Zhou
Oct 4, 2007·Basic & Clinical Pharmacology & Toxicology·Alexandra AccoAdelar Bracht
Feb 16, 2005·Expert Opinion on Pharmacotherapy·Carlo PalazziEmilio D'Amico
Aug 10, 2007·Expert Opinion on Pharmacotherapy·Katerina AntoniouAlexandros A Drosos
Aug 20, 2004·Pharmacological Reviews·Daniel L SimmonsTimothy Hla
Aug 11, 2017·Journal of Clinical Gastroenterology·Pavan K MukthinuthalapatiMarwan Ghabril
Oct 25, 2016·Transplantation·Frank Alexander SchildbergRené Hany Tolba
Mar 17, 2001·Scandinavian Journal of Rheumatology·F McKennaG S Geis
Feb 5, 2002·Expert Opinion on Pharmacotherapy·A Bennett, I A Tavares
Nov 7, 2007·Drugs·James E Frampton, Gillian M Keating
Apr 12, 2014·Oncotarget·Tian-Huei ChuMing-Hong Tai
Nov 20, 2018·Clinics and Research in Hepatology and Gastroenterology·E LarreyR Anty
Sep 28, 2005·Gastroenterología y hepatología·M García-CortésR Alcántara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.